Ribbon’s IP Optical Solutions Selected By American Electric Power For Supply Chain Reliability And Enhanced Network Capabilities

Agreement highlights the value of speedy delivery and targeted solutionsPLANO, Texas, Feb. 8, 2024 /PRNewswire/ — Ribbon Communications Inc. (NASDAQ:RBBN), a global provider of real time communications technology

Agreement highlights the value of speedy delivery and targeted solutions

PLANO, Texas, Feb. 8, 2024 /PRNewswire/ — Ribbon Communications Inc. (NASDAQ:RBBN), a global provider of real time communications technology and IP optical networking solutions to many of the world’s largest service providers, enterprises, and critical infrastructure operators to modernize and protect their networks, today announced that American Electric Power (AEP) which maintains and operates the nation’s largest electricity transmission system, has added Ribbon’s IP and Optical products as one of its solutions to continue providing the critical communications needs to support AEP’s infrastructure.

Today’s utilities are required to digitize their assets, both in order to meet regulatory and security mandates, and to expand their offer with new services, reduced carbon emissions and improved maintenance, safety and security. Ribbon’s IP and Optical solutions, combined with a single management system, deliver field proven solutions to support and facilitate this transformation.

“AEP is a leader in the utilities sector, and its extensive network is a key part of our national infrastructure,” said Dave Hogan, Vice President, Enterprise & Government Markets from Ribbon. “We’re pleased to provide them with the high quality, secure and reliable IP Optical solutions that fulfill their stringent requirements and timetables.”

Total
0
Shares
Related Posts
Read More

Scribe Therapeutics Expands Collaboration With Sanofi To Advance In Vivo Genetic Medicines For Sickle Cell And Other Genomic Diseases; Scribe To Receive $40M Upfront, With The Potential For More Than $1.2B In Milestones Across All Programs

Predicated on the progress of the companies' first collaboration, Sanofi has selected Scribe's novel CRISPR by Design™ approach to drive forward a new wave of in vivo genetic medicines Sanofi and Scribe

SNY